Revenue

The animal health leader faces scrutiny in its Q2 earnings call after a rocky first quarter. All eyes are on its strategy to balance market pressures with future-focused bets.

Triller's audacious acquisition of a SpaceX stake sends its stock soaring, but can this high-stakes bet on a space giant save a company plagued by financial woes?

Wheels Up partners with Surf Air Mobility, leveraging Palantir's AI to overhaul its operations, signaling a tech-driven transformation for luxury air travel.

Co-Dx's local-first strategy empowers communities against disease, but can this innovative public health play overcome the company's financial headwinds?

As Aritzia prepares its Q1 FY27 results, all eyes are on whether the fashion house can sustain its meteoric growth and defy a turbulent retail landscape.

A new report reveals hotels injected $12B into San Francisco's economy. We dive into the public-private strategy driving this comeback and its ripple effect.

Atlantic International regained Nasdaq compliance, but its record revenue and massive new contracts can't hide the cautionary tale of a company stretched thin by global M&A.

As Abbott prepares its July 16th earnings report, all eyes are on more than just the balance sheet. It's a test of its post-acquisition strategy.

Nanox reports revenue growth but a shrinking cash pile and a stark warning about its future, forcing a strategic retreat from guidance amid legal troubles.

Awani Capital's merger of two roofing firms signals a major shift in home services, betting on a cash-only model to consolidate a fragmented, high-demand market.

Automotive tech giant Visteon announced a massive share repurchase, delighting Wall Street. But in an industry demanding relentless innovation, is this the best use of capital?

Freedom Holding Corp. secured a key S&P upgrade for its subsidiaries, bolstering its aggressive global expansion. But can its risk controls keep pace?

With its stock lagging despite strong sales, Insulet brings on a proven value-creator. Can the 'Mazelsky Playbook' accelerate growth and fend off rivals?

Verano's upcoming Q2 report is a key indicator for the cannabis sector. We look at the strategic moves, from stock splits to rescheduling, setting the stage.

The lender's 10% yield attracts income investors, but a tight payout ratio and market shifts raise questions about its long-term sustainability.

Beyond the press release, MegaGen's investment in BIOLASE is a strategic masterclass in post-acquisition revival, aiming to dominate the dental tech market.

A landmark acquisition is set to 4x IQSTEL's net income. But the real story is its pivot from a low-margin carrier to a high-margin digital services powerhouse.

KKR's accelerated capital returns and a major reporting overhaul reveal a recovering private equity landscape, a crucial sign for tech firms awaiting exits.

Engineering giant AtkinsRéalis secures a £340M role in a landmark UK government framework, positioning it at the heart of national security and renewal.

With a new dispensary in a former coffee shop on a key commuter route, C3 Industries is testing if a classic retail playbook can win in a market challenged by high prices.